Antengene Corporation Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022🗂️ Report periods on file: 2022, 2020

In its 2022 reporting, Antengene Corporation Limited disclosed greenhouse gas emissions of 1.6K tonnes of CO2e. By scope: Scope 1: 551.32 tonnes of CO2e; Scope 2: 1.1K tonnes of CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
1.6K tonnes of CO2e
2022
💧
Water Usage
8.0K tonnes
2022
♻️
Waste
56.7K kg
2022
⚙️
Energy Use
1.8M kWh
2022

📊 Emissions by Scope (2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).551.32 tonnes of CO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.1.1K tonnes of CO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20221.6K tonnes of CO2e
2020278.47 tonnes of CO2e

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Compliant operationsBusiness ethicsQuality control and safety of productsTechnology development and product innovationIntellectual property protectionPrivacy and data protectionSafety of and communication with clinical trial participantsEmployees’ health and safetyEmissions control (including exhaust emissions, greenhouse gases emissions and wastewater discharge)Waste disposal and managementInternational strategic cooperationImproving corporate governanceResponsible procurement and supply chain managementTraining and development of employeesEmployee welfareEmployee rights/Labour standardsEmployee diversity and equal opportunitiesWater consumption and efficiencyEnergy consumption and efficiencyMitigation and adaptation of climate changeCommunity charity

⚠️ Challenges & Risks +

  • Launch of XPOVIO® (selinexor, ATG-010) in mainland China was delayed because of government covid-zero policy measures in the second quarter of 2022
  • Travel and hospital restrictions and regional covid-zero policy across major cities in the second half of 2022 and the major shift in China’s COVID-19 policy in December 2022 has impacted our commercialization negatively

📋 Report Information

Reporting Period: 2022